01 / Vendor Profile
NATIONAL DISEASE RESEARCH INTERCHANGE Federal Contracts and Awards
UEI F696R1G6DN85 · CAGE 1Q631
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $2.72M in net contract obligations to NATIONAL DISEASE RESEARCH INTERCHANGE across 39 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
NATIONAL DISEASE RESEARCH INTERCHANGE contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$469.2K
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $359.7K | 7 | 2 | — |
| FY 2021 | $608.3K | 6 | 2 | +69.1% |
| FY 2022 | $100.6K | 5 | 1 | −83.5% |
| FY 2023 | $400.7K | 7 | 2 | +298.4% |
| FY 2024 | $512.1K | 4 | 1 | +27.8% |
| FY 2025 | $272.0K | 4 | 1 | −46.9% |
| FY 2026 | $469.2K | 6 | 2 | +72.5% |
04 / Federal Customers
Which federal agencies buy from NATIONAL DISEASE RESEARCH INTERCHANGE?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 3600 | $2.63M | 30 | 96.7% | |
| 7529 | $90.3K | 9 | 3.3% |
05 / Contracting Offices
Which contracting offices buy from NATIONAL DISEASE RESEARCH INTERCHANGE?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 36C241 | VETERANS AFFAIRS, DEPARTMENT OF | $2.63M | 30 | 96.7% | |
| 75N95B | NATIONAL INSTITUTES OF HEALTH | $95.0K | 1 | 3.5% | |
| 75N980 | NATIONAL INSTITUTES OF HEALTH | $10.0K | 2 | 0.4% | |
| 75N940 | NATIONAL INSTITUTES OF HEALTH | -$1.7K | 3 | -0.1% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | -$13.0K | 3 | -0.5% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541720 | RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES | $2.79M | 24 | 1 | 102.6% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $10.0K | 2 | 1 | 0.4% |
| 541910 | MARKETING RESEARCH AND PUBLIC OPINION POLLING | -$1.0K | 1 | 1 | 0.0% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | -$13.7K | 5 | 1 | -0.5% |
| 621991 | BLOOD AND ORGAN BANKS | -$66.5K | 7 | 2 | -2.4% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| Q515 | MEDICAL- PATHOLOGY | $2.42M | 19 | 1 | 89.0% |
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $371.6K | 7 | 1 | 13.6% |
| 6555 | HUMAN TISSUE AND CADAVERS | $95.0K | 1 | 1 | 3.5% |
| Q301 | REFERENCE LABORATORY TESTING | $10.0K | 2 | 1 | 0.4% |
| 6505 | DRUGS AND BIOLOGICALS | -$1.7K | 3 | 1 | -0.1% |
| 6509 | DRUGS AND BIOLOGICALS, VETERINARY USE | -$13.0K | 3 | 1 | -0.5% |
| AN51 | R&D- MEDICAL: MENTAL HEALTH (BASIC RESEARCH) | -$161.5K | 4 | 1 | -5.9% |
08 / Competition Pattern
How was NATIONAL DISEASE RESEARCH INTERCHANGE’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for NATIONAL DISEASE RESEARCH INTERCHANGE?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N95B26P00037 | Sep 28, 2026 | $95.0K | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH | 621991 | 6555 |
10 / Interpreting the Profile
How should you evaluate NATIONAL DISEASE RESEARCH INTERCHANGE as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.